Arizona Cancer Therapeutics is managed by Alliance Therapeutics
Arizona Cancer Therapeutics is a private biopharmaceutical company developing targeted peptide-based therapies for the treatment of cancer. Arizona Cancer Therapeutics, LLC is an early-stage biopharmaceutical company focused on commercializing therapeutic peptides for oncology. Founded in 2011, the company is committed to developing novel, non-toxic treatment alternatives to existing therapies that have limited efficacy and unwanted side-effects for the treatment of metastatic cancer. ACT is funded by private investors and grants from National Institutes of Health and State of Arizona.
Use our contact page if you are interested in investment opportunities.